PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
AboutPricing
Company ReportsMcGuff Pharmaceuticals
McGuff Pharmaceuticals
Download report
Favorite
Financial
Marketed Drugs
Clinical Trials
Financial
Stock price
No data
Company Revenue
No data
Revenue by Drug
Loading
Marketed Drugs
Therapeutic Areas:
All
Classification:
All
Include Generics:
Trade Name
Drug Name
Approved
Patent Expires
Indication
AscorAscorbic acid2017-10-022024-2033
Common cold
,
Constipation
,
Methemoglobinemia
,
Penetrating wounds
,
Tyrosinemias
,
Scurvy
,
Hypercholesterolemia
,
Hypophosphatemia
,
Hypertriglyceridemia
,
Peripheral vascular diseases
,
Dermatitis
,
Alcoholic neuropathy
,
Seizures
,
Vitamin a deficiency
,
Hypoparathyroidism
,
Inborn errors metabolism
,
Photosensitivity disorders
,
Thiamine deficiency
,
Folic acid deficiency
,
Rickets
,
Vitamin b 6 deficiency
,
Megaloblastic anemia
,
Vitamin b deficiency
,
Xerophthalmia
,
Wernicke encephalopathy
,
Beriberi
,
Night blindness
,
Riboflavin deficiency
,
Pellagra
,
Chronic kidney failure
,
Cardiovascular diseases
,
Psoriasis
,
Lung neoplasms
,
Crohn disease
,
Skin neoplasms
,
Familial hypophosphatemic rickets
,
Osteoporosis
Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Drug Name
Phase 1
Phase 2
Phase 3
Phase 4
Indication
Ascorbic acid
hepatitis b
,
chronic hepatitis b
,
hepatitis
,
hepatitis a
,
hepatitis c
,
chronic hepatitis c
,
chronic hepatitis
Aglatimagene besadenovec
prostatic neoplasms
,
castration-resistant prostatic neoplasms
,
breast neoplasms
,
ovarian neoplasms
Bevifimod
clostridium infections
Doxecitine
triple negative breast neoplasms
,
squamous cell carcinoma of head and neck
,
pharyngeal neoplasms
,
peritoneal neoplasms
,
pancreatic neoplasms
,
stomach neoplasms
,
neoplasms
,
adenocarcinoma
,
pancreatic ductal carcinoma
,
rectal neoplasms
,
esophageal neoplasms
,
small cell lung carcinoma
,
liver neoplasms
,
ovarian epithelial carcinoma
,
brain neoplasms
,
urologic neoplasms
,
non-muscle invasive bladder neoplasms
,
castration-resistant prostatic neoplasms
,
endometrial neoplasms
,
hepatocellular carcinoma
,
adenocarcinoma of lung
,
renal cell carcinoma
,
prostatic neoplasms
,
sarcoma
,
breast neoplasms
,
biliary tract neoplasms
,
urinary bladder neoplasms
,
neoplasm metastasis
,
cholangiocarcinoma
,
colorectal neoplasms
,
carcinoma
,
lung neoplasms
,
ovarian neoplasms
,
esophageal squamous cell carcinoma
,
gallbladder neoplasms
,
transitional cell carcinoma
,
fallopian tube neoplasms
,
bile duct neoplasms
,
endometrioid carcinoma
,
mucinous cystadenocarcinoma
,
acinar cell carcinoma
,
unknown primary neoplasms
,
klatskin tumor
,
non-small-cell lung carcinoma
Retinol
colorectal neoplasms
,
non-hodgkin lymphoma
,
hodgkin disease
,
healthy volunteers/patients
,
melanoma
,
type 2 diabetes mellitus
,
pancreatic neoplasms
,
renal cell carcinoma
,
kidney neoplasms
,
leukemia
,
hematologic neoplasms
,
lymphoma
,
sezary syndrome
,
b-cell chronic lymphocytic leukemia
,
prolymphocytic leukemia t-cell
,
t-cell lymphoma
,
prolymphocytic leukemia
,
t-cell lymphoma peripheral
,
t-cell lymphoma cutaneous
,
prolymphocytic leukemia b-cell
,
adenocarcinoma
,
non-small-cell lung carcinoma
,
osteoporosis
,
postmenopausal osteoporosis
,
hiv
Taxane
ovarian neoplasms
,
fallopian tube neoplasms
,
ovarian epithelial carcinoma
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use